“Imaging biomarkers for the efficacy evaluation of regenerative medicine”
As surrogate endpoint, medical imaging has been utiliezed for efficacy assessment of the pharmaceutical products. In addition, imaging biomarkers are of courese useful for regenerative medicine efficacy assessment. In this video, we introduce up and coming imaging biomarkers with our experiences.
Category
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.